Literature DB >> 23406284

The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients.

D J Malinoski1, M S Patel2, O Ahmed3, M C Daly3, S Mooney3, C O Graybill4, C E Foster3, A Salim5.   

Abstract

Many organ procurement organizations (OPOs) utilize preset critical care endpoints as donor management goals (DMGs) in order to standardize care and improve outcomes. The objective of this study was to determine the impact of meeting DMGs on delayed graft function (DGF) in renal transplant recipients. All eight OPOs of the United Network for Organ Sharing Region 5 prospectively implemented nine DMGs in every donor after neurologic determination of death (DNDD). "DMGs met" was defined a priori as achieving any seven of the nine DMGs and this was recorded at the time of consent for donation to reflect donor hospital ICU management, 12-18 h later, and prior to organ recovery. Multivariable analyses were performed to identify independent predictors of DGF (dialysis in the first week after transplantation) with a p<0.05. A total of 722 transplanted kidneys from 492 DNDDs were included. A total of 28% developed DGF. DMGs were met at consent in 14%, 12-18 h in 32% and prior to recovery in 38%. DGF was less common when DMGs were met at consent (17% vs. 30%, p=0.007). Independent predictors of DGF were age, Cr and cold ischemia time, while meeting DMGs at consent was significantly protective. The management of potential organ donors prior to consent affects outcomes and should remain a priority in the intensive care unit. No claim to original US government worksJournal compilation
© 2013 The American Society ofTransplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2013        PMID: 23406284     DOI: 10.1111/ajt.12090

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

1.  Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial.

Authors:  Peter Schnuelle; Wilhelm H Schmitt; Christel Weiss; Antje Habicht; Lutz Renders; Martin Zeier; Felix Drüschler; Katharina Heller; Przemyslaw Pisarski; Bernhard Banas; Bernhard K Krämer; Matthias Jung; Kai Lopau; Christoph J Olbricht; Horst Weihprecht; Peter Schenker; Johan W De Fijter; Benito A Yard; Urs Benck
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-17       Impact factor: 8.237

2.  Hepatic stellate cell and myofibroblast-like cell gene expression in the explanted cirrhotic livers of patients undergoing liver transplantation.

Authors:  J Michael Estep; Linda O'Reilly; Geraldine Grant; James Piper; Johann Jonsson; Arian Afendy; Vikas Chandhoke; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2009-08-13       Impact factor: 3.199

3.  Induction of Hepatic and Endothelial Differentiation by Perfusion in a Three-Dimensional Cell Culture Model of Human Fetal Liver.

Authors:  Christopher Pekor; Jörg C Gerlach; Ian Nettleship; Eva Schmelzer
Journal:  Tissue Eng Part C Methods       Date:  2015-02-11       Impact factor: 3.056

4.  The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada.

Authors:  Paul Douglas Renfrew; Hude Quan; Christopher James Doig; Elijah Dixon; Michele Molinari
Journal:  Can J Gastroenterol       Date:  2011-07       Impact factor: 3.522

5.  Deceased organ donor factors influencing pancreatic graft transplantation and survival.

Authors:  Mitchell B Sally; Margaret Katherine Ellis; Michael Hutchens; Tahnee Groat; Elizabeth Swanson; Madhukar S Patel; Claus U Niemann; Darren J Malinoski
Journal:  Clin Transplant       Date:  2019-06       Impact factor: 2.863

Review 6.  Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?

Authors:  Burcin Ekser; Bruno Gridelli; A Joseph Tector; David K C Cooper
Journal:  Transplantation       Date:  2009-11-15       Impact factor: 4.939

7.  Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function.

Authors:  Elizabeth A Swanson; Madhukar S Patel; Tahnee Groat; Nora E Jameson; Margaret K M Ellis; Michael P Hutchens; Claus U Niemann; Darren J Malinoski; Mitchell B Sally
Journal:  J Trauma Acute Care Surg       Date:  2020-06       Impact factor: 3.697

Review 8.  The development and current status of Intensive Care Unit management of prospective organ donors.

Authors:  Margaret Kathleen Menzel Ellis; Mitchell Brett Sally; Darren Malinoski
Journal:  Indian J Urol       Date:  2016 Jul-Sep

9.  Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients.

Authors:  Vincent Vuiblet; Michael Fere; Ezechiel Bankole; Alain Wynckel; Cyril Gobinet; Philippe Birembaut; Olivier Piot; Philippe Rieu
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

10.  Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals.

Authors:  Tainá Veras de Sandes-Freitas; Cláudia Rosso Felipe; Wilson Ferreira Aguiar; Marina Pontello Cristelli; Hélio Tedesco-Silva; José Osmar Medina-Pestana
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.